MoneyWorks4Me

Shamrock Indl. Co - Quaterly Results

27 May 2024 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the March 2024 quarter as against Rs. 0.00 millions during year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -0.19 millions as compared to Net Loss of Rs. -0.23 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 improved to -0.19% as compared to -0.22% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 1.12 0.00 0.00 1.12 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.19 -0.22 -13.64 -0.40 -1.28 -68.75 -0.40 -1.28 -68.75
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.19 -0.22 -13.64 -0.40 -1.28 -68.75 -0.40 -1.28 -68.75
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.19 -0.22 -13.64 -0.40 -1.28 -68.75 -0.40 -1.28 -68.75
TAX 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.19 -0.23 -17.39 -0.40 -1.29 -68.99 -0.40 -1.29 -68.99
Equity 54.28 54.28 0.00 54.28 54.28 0.00 54.28 54.28 0.00
PBIDTM(%) 0.00 0.00 0.00 -35.71 0.00 0.00 -35.71 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..